“…143,144 Colleges and schools of pharmacy should ensure that, like medical school graduates, 145 students receive the opioid use disorder and DATA waiver training integrated into their didactic education, much like naloxone, 83,142,146 medication therapy management, 147,148 and immunization certification training. 149 This interdisciplinary core curriculum integrated with other SUD treatment providers and educators should be adapted for student pharmacists, pharmacy residents and practicing pharmacists in the form of continuing professional education and certification. This curriculum would ideally, at minimum, cover screening, risk factors, stigma, harm reduction including naloxone, motivational interviewing, medication therapy management of SUD, person-first language, and how to deliver culturally competent care.…”